Yeon Hee Park

Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor–Positive Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer: Primary Results From TROPION-Breast01

Aditya Bardia, Komal Jhaveri, Seock‐Ah Im et al. · Journal of Clinical Oncology · 2024 · 140 citations · Full text

Medicine, Oncology, Pharmacology +17

Genomic characteristics of triple negative apocrine carcinoma: a comparison to triple negative breast cancer

Ji‐Yeon Kim, Sabin Park, Eun Yoon Cho et al. · Experimental & Molecular Medicine · 2023 · 19 citations · Full text

Medicine, Genetics, Oncology +14

Clinical advantage of targeted sequencing for unbiased tumor mutational burden estimation in samples with low tumor purity

Tae Hee Hong, Hongui Cha, Joonho Shim et al. · Journal for ImmunoTherapy of Cancer · 2020 · 17 citations · Full text

Medicine, Immunology, Oncology +17

Progesterone Receptor Expression Level Predicts Prognosis of Estrogen Receptor-Positive/HER2-Negative Young Breast Cancer: A Single-Center Prospective Cohort Study

Youngji Kwak, Sung Yoon Jang, Joon Young Choi et al. · Cancers · 2023 · 16 citations · Full text

Medicine, Oncology, Breast Oncology +13

Clinical Characteristics and Exploratory Genomic Analyses of Germline BRCA1 or BRCA2 Mutations in Breast Cancer

Sehhoon Park, Seri Park, Sohee Lee et al. · Molecular Cancer Research · 2020 · 15 citations · Full text

Life Sciences, Genetics, Oncology +17